牙真菌干细胞衍生出的分泌物诱导的舌头瘤重编程微环境
Ferry Sandra1,2, Dewi Ranggaini3, Johni Halim3
1Department of Biochemistry and Molecular Biology, Division of Oral Biology, Faculty of Dentistry, Universitas Trisakti, Indonesia.
European journal of dentistry
|February 16, 2026
概括
牙纸干细胞衍生分泌体 (DPSC-Sec) 在口腔舌癌中显示出重编程瘤微环境 (TME) 的前景. 这种方法可以通过调节关键的TME组件来克服治疗阻力.
科学领域:
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
- 癌症 微环境 研究 研究
背景情况:
- 口舌癌具有攻击性,其瘤微环境 (TME) 推动了进展和治疗耐药性.
- 目前的治疗方法不足以解决TME的复杂性,需要新的策略.
- 牙纤维干细胞衍生秘密体 (DPSC-Sec) 为TME调节提供了丰富的生物活性分子来源.
研究的目的:
- 审查DPSC-Sec在重新编程口腔舌癌的TME方面的潜力.
- 探索DPSC-Sec在TME中的行动机制.
- 讨论临床翻译的挑战和未来方向.
主要方法:
- 对DPSC-Sec和舌头癌症的临床前研究的文献综述.
- 分析DPSC-Sec的分子成分及其对TME细胞的影响.
- 对DPSC-Sec对癌症相关纤维细胞,免疫细胞,细胞外基质和血管生成的影响的证据的评估.
主要成果:
- DPSC-Sec显示出抑制癌症相关纤维细胞和重编程免疫抑制细胞的潜力.
- 它可以重塑细胞外基质,使血管生成正常化,并调节瘤性途径.
- 原始化方法显著影响DPSC-Sec的治疗功效.
结论:
- DPSC-Sec是一种有前途的治疗剂,用于调节舌癌TME.
- 免疫能力模型的进一步验证和严格的安全评估对于临床转换至关重要.
- 与生物材料或传统疗法结合的策略可以提高疗效.
更多相关视频
09:30Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
Published on: January 7, 2019
10.9K
05:45In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
Published on: January 9, 2020
8.4K
相关概念视频
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K